Zyn Pouches Price - Search News

FDA Approves Sale of ZYN Nicotine Pouches

Stocktwits on MSN · 18h

Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat

Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA) authorized marketing of its Zyn nicotine pouch products, lifting retail sentiment.

Business Insider · 14h

Philip Morris Gains Competitive Edge with FDA Authorization of ZYN Nicotine Pouches

Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of

Benzinga.com · 13h

ZYN Nicotine Pouches Receive FDA Marketing Approval

The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products meet public health standards and present lower risks than cigarettes and smokeless tobacco.

1d

Federal health officials authorize Zyn nicotine pouches, citing potential to help adult smokers cut back or quit

Federal health officials authorize Zyn nicotine pouches, citing potential to help adult smokers cut back or quit.

FDA Approves Marketing of Nicotine Pouches

Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results